Canada’s cosmetic animal-testing ban took effect on December 22, 2023, but that date does not erase every earlier study. The rules distinguish conducting a test, relying on data to establish cosmetic safety and making an animal-testing claim. Three hypothetical timelines show why the dates of the study and the product’s Canadian sale must remain separate.
The first timeline concerns a study completed before the ban and used for a later product. The second follows an existing cosmetic through reformulation. The third asks whether an earlier history can authorize a proposed new test. Each question turns on a different event, so each needs its own answer.
Draw the test and sale dates on separate lines
Health Canada’s explanation of the ban identifies both Canadian testing restrictions and rules governing reliance on animal-testing data for cosmetics sold here. It also addresses claims about the absence of animal testing. A statement about one of those subjects should not silently become an answer about all three.
Begin an imaginary timeline with three distinct events: a study was conducted, a particular formula was sold in Canada, and somebody made a claim about testing. Those events may happen in different years. Writing one date beside the product’s name cannot tell the whole story unless you know which event that date describes.
For example, “introduced in 2025” could describe the first Canadian sale of a product. It does not say when every study used to support its safety was performed. Similarly, a study from 2021 does not establish that a cosmetic containing the studied ingredient was already sold in Canada in 2021. Neither date should be recruited to do the other’s work.
All the products and dates below are invented teaching examples. No testing history is being attributed to a spa, a manufacturer or a product range. Holding the examples at that level makes it possible to explain a definite rule without implying access to a real company’s safety files.
An old study can remain usable for a later cosmetic
In the first example, a business has animal-testing data from a study conducted in June 2022. A new cosmetic is first sold in Canada in March 2025. The question is whether the later product introduction automatically makes the earlier study unusable under the ban’s data-reliance rules.
The answer to that narrow question is no. Section 3.2.4 of the federal guidance describes an exception for data from tests conducted before December 22, 2023. The study in the example precedes that date. Introducing the cosmetic later does not change the historical date on which the study was conducted.
The exception does not mean that the old study is adequate evidence for every imaginable product. Adequacy of safety evidence is a separate issue. The resolved point is permission to rely on previously generated data under that particular exception, rather than an automatic requirement to disregard the study merely because the product is new.
Change one fact and the reasoning must be reopened. If the test actually took place in June 2024, calling the report an update to an older file would not turn it into a 2022 test. A document’s filing label and the date of the test it records are different things. The relevant fact cannot be repaired by renaming the folder.
This is why a shopper’s question “Is the product new?” cannot settle the whole ethical history. A new product can draw on older information. The word new describes the product’s introduction in this example, while the exception turns on when the data-producing test occurred.
A preexisting formula has a different exception
In the second example, a cosmetic was sold in Canada in October 2023 and remains the same formula afterward. Section 3.2.5 addresses cosmetics sold in Canada before the prohibition came into force. It supplies a different exception from the old-study provision: the earlier sale of the cosmetic is the relevant event.
Now suppose the business reformulates that product in 2025. The guidance says reformulation removes the ability to rely on the preexisting-product exception. Keeping the same name on the front of the bottle does not preserve that particular exception for the changed formula. The product-name timeline and formulation timeline have diverged.
That change does not by itself prove that no permissible evidence can support the reformulated cosmetic. Other allowable evidence or exceptions need their own assessment. The definite conclusion is that the earlier-sale exception cannot simply be carried forward on the strength of the familiar name.
Apply that distinction to the Casmara masks among the facial products named by Santé. The date you book a facial is not the formula’s first Canadian sale date. For an earlier-sale question, identify the particular formula and its Canadian chronology. Moving your appointment from October to November would change your calendar, while leaving the product’s evidence timeline exactly where it was.
A new cosmetics-only test cannot borrow the old date
The third example concerns conduct rather than the two data exceptions. Imagine a proposed test in Canada in 2025 that could cause an animal pain, suffering or injury, undertaken to satisfy a cosmetic safety requirement. An earlier Canadian sale or an old study does not make that proposed activity an old event.
Health Canada’s guidance explains the prohibition on conducting that kind of test in Canada. The proposed test falls on the prohibited side of that rule. This conclusion concerns the specified harmful-test conduct and cosmetic purpose; it does not say that every interaction with an animal is prohibited or decide the sale status of every product tested abroad.
Keep the three answers attached to their cases. The 2022 study can fall within the previously generated data exception despite a later product launch. The unchanged preexisting cosmetic has its own exception, which reformulation removes. The proposed new Canadian test cannot inherit either event’s old date. A timeline that preserves those differences explains more than a blanket claim that the ban erased all animal-testing history.